We describe an uncommon severe clinical complication of sepsisthyrotoxic storm (TS). Common biologic, pathogenic, clinical conditions that can determine sepsis can cause a TS. High circulating values of vascular cellular adhesive molecules-1 and various pro-inflammatory citochines are related with thyroid damage. During sepsis, moderate dysfunctions are not expression of actual disease, but severe damage in pituitary-thyroid hormonal axis. Thyroid stimulated hormon release, and consequent overproduction of thyroid hormones can cause TS. In critical patients, presence of hormonal dysfunctions determines more elevated clinical score of sepsis severity and higher risk of death than control groups (without thyroid disease) or survived patients.
Introduction
Thyrotoxic storm (TS) is a clinical syndrome marked by strong adrenergic activation due to overproduction of triiodotironine (T3) and tiroxine (T4) and their metabolic effects. Pulmonary edema with depletion of circulating liquid volume, jaundice, renal insufficiency are manifestations of severe thyrotoxicosis. 1 TS is related to every cause that can produce an excessive thyroid hormones concentration. 2 If not adequately treated, TS is fatal, but mortality rate varies from 20 to 50%. 1 In the general population, incidence of sub-acute or acute hyperthyroidism varies from 0.05 to 0.1%. 1 TS appears in 10% of hospitalization for hyperthyroidism. 2 Infectious diseases and resulting systemic damages due to sepsis can determine TS and are considered as common causes of TS. 2, 3 In compromised hosts hospitalized in intensive care unit (ICU) -where multiple causes that can simulate TS are present -its precocious identification is difficult. 2 Literature data about its actual incidence in sepsis are poor. 4 Iatrogenic cause, like drugs amiodarone, benzofuranic iodine-enriched (37% of molecular pound), and anti-arrhythmic drug, can originate thyroid dysfunctions in 15-20%. 4 We describe a clinic case of TS during multidrug resistant (MDR) Klebsiella pneumoniae septic shock (SS) observed in ICU, in January 2012, and its biologic pathogenesis.
Materials and Methods
The patient, a 75-year-old woman with chronic atrial fibrillation treated with oral amiodarone (maintenance dose of 200 mg/die, administered five days a week), had an elective video-laparoscopic cholecystectomy for cholelithiasis. Surgical complications immediately arose: choleperitoneum, biliary-intestinal fistula, secondary and tertiary stercorary peritonitis, subsequent abdominal major surgery. Simplified acute physiology score II and sequential organ failure assessment were respectively 61 (high risk of severe prognosis) and 8 (high risk of organs failure). She showed persistent clinical complications, recurrent severe nosocomial infections, caused by MDR Gram-negative strains and Cytomegalovirus pneumonia as immunocompromised hosts, and multiple organs disease. In March 2012 (35 th day of hospital stay), despite previous normal thyroid function, during SS and ventilator acquired pneumonia caused by MDR K. pneumoniae, and vascular catheter-related bloodstream by methicillin-resistant Staphylococcus epidermidis, TS arose. Symptoms were violent fever (41°C), neurologic and psychic excitement, hypertension (180/100 mmHg), tachyarrhythmia (150/min heart-beats), atrial fibrillation, severe respiratory insufficiency, congestive heart failure, glycemic decompensation (HbA1c 9.5%), neutrophilic leukocytosis (with white blood cells 25,000/mmc and neutrophils 12,500/mmc). Serum thyroid hormonal values were: thyroidstimulating hormone (TSH)=0. 1.2/0.5 mg%) ]. Thyroid echography showed: parenchymal inhomogeneity and hypoechogenicity, anteriorposterior diameters of right and left lobe 15 and 12 mm. Endovenous antibiotic therapy was administered: vancomycin (1 g/48 h, with maintenance breaktrough plasmatic levels from 10 to 20 mg/L), colistimethate colistin (2,000,000 U/bid), meropenem (1 g/bid) and tigecycline (100 mg/die loading dose and 50 mg/bid maintenance dose), adjusting for kidney insufficiency. Therapy for TS, via nasogastric tube, was: prednisolone (30 mg/die), propranolol (40 mg/die) and thiamazole (60 mg/die). General and clinical conditions remained poor and unchanged. In 65 th day of hospital stay, serologic hormonal examination evidenced: TSH 0.2 mU/mL, T3 4.9 ng/mL, T4 30.5 ng/mL. Metabolic interactions between amiodarone and other administered drugs were not present. The patient survived the TS acute phase but died on her 154 th day in hospital because of all the clinical complications, including sepsis. Diagnosis of the described infections was posed according to the criteria of the American College of Chest Physician and Society of Critical Care Medicine. 5
Results and Discussion
TS case as presented is very rare in anesthesiology and infectious diseases clinic experiences. Clinical deterioration and multi-organ failure were the background in which TS appeared. SS was considered the TS trigger, with subsequent onset of pituitary-thyroid axis severe damage, thyrotropine release, T3 and T4 overproduction, TSH suppression, altered negative feedback of thyroid functions. 3, 6 Intranuclear cellular biologic activity explains pathogenesis of TS adrenergic activation: density increase of beta-adrenergic target receptors, post-receptors signals modification, genic activation and transcription induction by molecules after hormonal deiodination, antibodies for TSH receptor. 6 Pro-inflammatory cellular factors, released during SS, are responsible for the shared pathogenic support both for multi-organ failure, typical of SS and TS: interleukins (IL1b, IL-6), alpha-tumor necrosis factor (TNFa), vascular cellular adhesins-1 (VCAM-1). 6 Many clinical and biological studies demonstrate these combined interactions. IL1b, IL6, and TNFa can directly alter thyroid functions with various grades of clinical expression and severity, and can activate humoral reactions as in other organs and systems. 6, 7 TNFa is also the major pro-inflammation mediator active on hormonal and metabolic side. SS creates endothelial homeostasis alterations for vascular cellular adhesins-1, mostly VCAM-1, and can originate from phenotypic variation of endothelial cells towards a pro-inflammatory status. 8 Active leukocytes or other specific immunity cells can produce VCAM-1 activation too. 8 Therefore, as described in our case, systemic inflammatory response syndrome to SS, an excessive immunity response, anaphylaxis-like, which appears against various provocative bacterial antigens, mostly Gram-negative strains lipopolysaccharides, provides an inflammatory reactions cascade. 6, 7 
Conclusions
We evaluated if amiodarone-induced thyrotoxicosis (AIT) could be another possible cause of TS in our described case. Between the two clinical forms of AIT, AIT type 2 is the most frequent and, generally, it causes thyroiditis in subjects previously undamaged. 8 Amiodarone could have a role as cofactor in causing thyrotoxicosis during the onset of AIT type 2. 9 However, we think that the principal causes of such a devastating TS were biologic and immunologic alterations due to SS, which, in described clinical history, had a greater pathogenic role. According to scientific literature present on the subject, TNFa and VCAM-1 could be the strongest activators of inflammation, shared mediators of thyroid and septic damage, therefore the most probable causes of the set of symptoms described.
